Company / EPS (Diluted)
MARAVAI LIFESCIENCES HOLDINGS, INC. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.90
FY2025
5-year range
-$0.90 / $2.36
FY2021-FY2025
Trend
-153.9%
vs FY2024
Sector context
#83 of 204
Health Care
What the data says
At $-0.90, MARAVAI LIFESCIENCES HOLDINGS, INC.'s eps (diluted) ranks #83 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 7 years, ranging from $-0.90 in FY2025 to $2.36 in FY2022.
Based on SEC 10-K filings.
-0.90 in FY2025.
Declined from $1.56 to $-0.90 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#83 of 204 in Health CareTop 41% of 204This company -$0.90 Sector average -$0.89
▼
-1.6% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 153.9% year-over-year.
- Ranks #83 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.90 | -153.9% |
| FY2024 | $1.67 | +7.1% |
| FY2023 | $1.56 | -33.9% |
| FY2022 | $2.36 | +7966.7% |
| FY2021 | -$0.03 | -101.3% |
| FY2020 | $2.36 | +7966.7% |
| FY2019 | -$0.03 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026